Cargando…
Critical reappraisal of risk factors for occurrence of hepatocellular carcinoma in patients with hepatitis C virus
More than one and half of current cases of hepatocellular carcinoma in the US, Europe, and Japan are attributable to hepatitis C virus (HCV) infection. HCV is also the primary cause of death in patients with HCV-related cirrhosis, with annual incidences of 0.5%–5% in Europe and 4%–10% in Asia. Scree...
Autores principales: | Bruno, Savino, Savojardo, Daniela, Almasio, Piero L, Mondelli, Mario U |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3846922/ https://www.ncbi.nlm.nih.gov/pubmed/24367218 http://dx.doi.org/10.2147/HMER.S16991 |
Ejemplares similares
-
The optimal dose of ribavirin for chronic hepatitis C: From literature evidence to clinical practice: The optimal dose of ribavirin for chronic hepatitis C
por: Abenavoli, Ludovico, et al.
Publicado: (2011) -
Sex difference in the interaction of alcohol intake, hepatitis B virus, and hepatitis C virus on the risk of cirrhosis
por: Stroffolini, Tommaso, et al.
Publicado: (2017) -
Reappraisal of the Role of Alkaline Phosphatase in Hepatocellular Carcinoma
por: Huang, Chun-Wei, et al.
Publicado: (2022) -
The frequency of occurrence of Hepatocellular Carcinoma after direct antiviral therapy in Hepatitis C virus patients
por: Aziz, Bilal, et al.
Publicado: (2019) -
The Impact of Antiviral Therapy and the Influence of Metabolic Cofactors on the Outcome of Chronic HCV Infection
por: Persico, Marcello, et al.
Publicado: (2011)